about
Gastric cancer after positive screening faecal occult blood testing and negative assessmentFaecal haemoglobin concentrations vary with sex and age, but data are not transferable across geography for colorectal cancer screening.A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.Analysis of morphologic patterns of fine-needle aspiration of the breast to reduce false-negative results in breast cytology.Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?Predictors of random sextant biopsy outcome in screened men with PSA > 4 ng/mL and a negative sextant biopsy at previous screening. Experience in a population-based screening program in Florence.Impact of a new sampling buffer on faecal haemoglobin stability in a colorectal cancer screening programme by the faecal immunochemical test.Impact of preanalytical factors on fecal immunochemical tests: need for new strategies in comparison of methods.Analysis of false-negative and underreported smears in the Florence district screening program for cervical carcinoma.How to improve the performances of Fecal Immunological Tests (FIT): Need for standardization of the sampling and pre-analytical phases and revision of the procedures for comparison of methods.Guidance for faecal occult blood testing: quantitative immunochemical method (FIT-HB) in colorectal cancer screening programmes.Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy.The impact of immunochemical faecal occult blood testing on colorectal cancer incidenceInfluence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence districtColorectal cancer screening programme by faecal occult blood test in Tuscany: first round resultsBasic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult bloodScreening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests[Thyroid carcinoma as cystic nodule. The diagnostic role of cytology by needle aspiration]Colorectal cancer screening by fecal occult blood testing: results of a population-based experienceClinical impact (cost-effectiveness) of qualifying atypical squamous cells of undeterminate significance (ASCUS) in cases favoring a reactive or dysplastic processMeasuring interval cancers in population-based screening using different assays of fecal occult blood testing: the District of Florence experienceEvaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening seriesFree to total PSA ratio is not a reliable predictor of prostate biopsy outcomeComparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screeningOn the clinical usefulness of the free-to-total prostate-specific antigen ratioOverall evaluation of an immunological latex agglutination system for fecal occult blood testing in the colorectal cancer screening program of FlorenceRE: A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for HemoglobinEffects of fecal sampling on preanalytical and analytical phases in quantitative fecal immunochemical tests for hemoglobin
P50
Q28289391-1D6F2D62-3554-4152-84B0-930E2EFE3221Q30779641-4595229F-B701-4CA9-B926-4B9E0D94150BQ35156701-9B56B4E9-51D7-4908-8473-2AF9B14D3CCAQ36110685-21F2146D-B986-497B-93F4-C9E602B54C2EQ36609425-C65DC3A4-FD1E-4E93-89ED-E1185EAB89BAQ36609690-9251399F-4BD5-43B8-BC85-969E74BBA9D9Q37081068-2D240625-2022-4356-8B1D-9E75FE0EF4D7Q39689941-9D37C0C3-2B78-43C3-9777-4F4299F47305Q40714692-57B94209-BA0A-47E5-AD84-94E8C6B8FDF9Q40868297-B9669B39-D050-45E9-B2EB-91ACC686BE64Q41731838-C1FE2FA4-7839-4913-B82A-2E19B379C5E4Q44403724-7EAFDE0C-1ECB-4CF3-959A-112DB58C7CC1Q47612032-6BB37743-E3E3-4756-B744-24E21E32728CQ51506480-BD15C622-0039-44CE-AE6C-8F83B13EBC0AQ59193655-9C5E7D2F-4254-4520-BA52-B9EE177EB65FQ59193665-96943A1A-90D6-40B0-804B-AC4149FB770AQ59193669-AD8196B3-1448-4612-A76F-EC7596CDBCE1Q59193671-AEEF6F18-0D76-430C-8F34-56C6A6FCDE96Q59193674-3DAD0038-C03C-4741-B0CC-2B3ADBEA3725Q67784534-8653B880-674D-4963-A2F8-F776F3652999Q73328543-DA0BA3C8-2124-496C-BA47-0D3D0AA2BE5EQ73577206-0D626A82-3A27-427F-A35F-45EA2D6CF941Q73695529-D07A3801-8250-433B-A8BE-B215120D6F4DQ79169452-1930DAA7-95D0-4888-A344-BB5331A9E32EQ80462957-5A162AB4-A017-4951-BBCB-9931A2709739Q80480797-DD9DB8F2-C8BC-4F6F-B8DA-4A539BBB0E6DQ83372145-5B2D83DA-30A2-492D-9013-831C73E13A8DQ84734406-65BC993D-1F4A-4717-9D2A-3A4077F0F96BQ86504234-388B741D-DE87-4C52-B8AC-C174702FC183Q88009828-86FBB555-2E44-4919-9D04-A68E925AD18C
P50
description
researcher ORCID ID = 0000-0002-1870-4722
@en
wetenschapper
@nl
name
Tiziana Rubeca
@ast
Tiziana Rubeca
@en
Tiziana Rubeca
@es
Tiziana Rubeca
@nl
type
label
Tiziana Rubeca
@ast
Tiziana Rubeca
@en
Tiziana Rubeca
@es
Tiziana Rubeca
@nl
prefLabel
Tiziana Rubeca
@ast
Tiziana Rubeca
@en
Tiziana Rubeca
@es
Tiziana Rubeca
@nl
P31
P496
0000-0002-1870-4722